Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Sep;342(3):619-30.
doi: 10.1124/jpet.112.192138. Epub 2012 Jun 13.

Mitochondrial dysfunction in neurodegenerative diseases

Affiliations
Review

Mitochondrial dysfunction in neurodegenerative diseases

Ashu Johri et al. J Pharmacol Exp Ther. 2012 Sep.

Abstract

Neurodegenerative diseases are a large group of disabling disorders of the nervous system, characterized by the relative selective death of neuronal subtypes. In most cases, there is overwhelming evidence of impaired mitochondrial function as a causative factor in these diseases. More recently, evidence has emerged for impaired mitochondrial dynamics (shape, size, fission-fusion, distribution, movement etc.) in neurodegenerative diseases such as Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and Alzheimer's disease. Here, we provide a concise overview of the major findings in recent years highlighting the importance of healthy mitochondria for a healthy neuron.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Structures of the compounds that produce beneficial effects in mice against mitochondrial dysfunction.

Similar articles

Cited by

References

    1. Beal MF. (2005) Mitochondria take center stage in aging and neurodegeneration. Ann Neurol 58:495–505 - PubMed
    1. Beal MF. (2007) Mitochondria and neurodegeneration. Novartis Found Symp 287:zpg183–192; discussion 192–186 - PubMed
    1. Beal MF. (2009) Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease. Parkinsonism Relat Disord 15 (Suppl 3):S189–S194 - PubMed
    1. Beal MF. (2011) Neuroprotective effects of creatine. Amino Acids 40:1305–1313 - PubMed
    1. Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT. (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181–4192 - PMC - PubMed

Publication types